Diabetes Hospitalizations and Deaths in a Cohort of Treatment-seeking Illicit Drug Users

Overview

Journal SAGE Open Med

Publisher Sage Publications

Specialty General Medicine

Date 2018 Jun 9

PMID 29881602

Citations 2

Authors

Alex Aregbesola

Ifeoma N Onyeka

Olubunmi Olubamwo

Kimmo Ronkainen

Jari Tiihonen

Jaana Fohr

Jussi Kauhanen

Affiliations

Soon will be listed here.

Abstract

Background: Studies on diabetes among illicit drug users are scarce in Finland. This study aimed to describe hospitalization and death due to diabetes among treatment-seeking illicit drug users.

Methods: Information of 4817 treatment-seeking drug users (3365 men and 1452 women) aged 11-65 years (mean 24.5 years) was linked to the Finnish national hospital discharge register and the national death registry to identify those clients who were hospitalized or died from diabetes mellitus during 1997-2013.

Results: Fifty-three persons (42 men and 11 women) had primary diagnoses of diabetes, with a total of 146 hospitalizations (121 among men and 25 among women). The total length of stay among men (1183 days) far exceeded those of women (138 days). Overall, type 1 diabetes was the main contributor to hospitalizations (67%, n = 98/146). The proportion of Type 1 diabetes with complications was 31% in men (n = 37/121) and 44% in women (n = 11/25). All cases of deaths due to diabetes (n = 7) occurred in men.

Conclusion: Diabetes hospitalizations were mainly due to Type 1 diabetes. Longer length of hospital stay was observed in men, and all diabetes deaths occurred among men. Male drug users and drug users in general would require more support to reduce morbidity and mortality due to diabetes.

Citing Articles

Assessment of Bacterial Infections and Antibiotic Regimens in Intravenous Drug Users.

Rehman S, Arif S, Ushakumari L, Amreen J, Nagelli A, Moonnumackel S Cureus. 2023; 15(9):e45716.

PMID: 37868523 PMC: 10590200. DOI: 10.7759/cureus.45716.

Hepatitis Risk in Diabetes Compared to Non-Diabetes and Relevant Factors: A Cross-Sectional Study with National Health and Nutrition Examination Survey (NHANES), 2013-2018.

Han J, Kwon J, Kim S, Lee H Int J Environ Res Public Health. 2023; 20(6).

PMID: 36981870 PMC: 10049568. DOI: 10.3390/ijerph20064962.

References

Carlsson S, Hammar N, Grill V, Kaprio J . Alcohol consumption and the incidence of type 2 diabetes: a 20-year follow-up of the Finnish twin cohort study. Diabetes Care. 2003; 26(10):2785-90. DOI: 10.2337/diacare.26.10.2785. View

Peyrot M, Rubin R, Kruger D, Travis L . Correlates of insulin injection omission. Diabetes Care. 2010; 33(2):240-5. PMC: 2809256. DOI: 10.2337/dc09-1348. View

Zhu V, Tu W, Rosenman M, Overhage J . Nonadherence to Oral Antihyperglycemic Agents: Subsequent Hospitalization and Mortality among Patients with Type 2 Diabetes in Clinical Practice. Stud Health Technol Inform. 2015; 216:60-3. View

Martinez-Aguayo A, Araneda J, Fernandez D, Gleisner A, Perez V, Codner E . Tobacco, alcohol, and illicit drug use in adolescents with diabetes mellitus. Pediatr Diabetes. 2007; 8(5):265-71. DOI: 10.1111/j.1399-5448.2007.00307.x. View

Nyenwe E, Loganathan R, Blum S, Ezuteh D, Erani D, Wan J . Active use of cocaine: an independent risk factor for recurrent diabetic ketoacidosis in a city hospital. Endocr Pract. 2007; 13(1):22-9. DOI: 10.4158/EP.13.1.22. View

Morris A, Boyle D, McMahon A, Greene S, MacDonald T, Newton R . Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997; 350(9090):1505-10. DOI: 10.1016/s0140-6736(97)06234-x. View

Skinner T . Recurrent diabetic ketoacidosis: causes, prevention and management. Horm Res. 2002; 57 Suppl 1:78-80. DOI: 10.1159/000053320. View

Musey V, Lee J, Crawford R, Klatka M, McAdams D, Phillips L . Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis. Diabetes Care. 1995; 18(4):483-9. DOI: 10.2337/diacare.18.4.483. View

Gilbert J, Byard R . Fatal Diabetic Ketoacidosis-A Potential Complication of MDMA (Ecstasy) Use. J Forensic Sci. 2017; 63(3):939-941. DOI: 10.1111/1556-4029.13602. View

10.

Onyeka I, Uosukainen H, Korhonen M, Beynon C, Bell J, Ronkainen K . Sociodemographic characteristics and drug abuse patterns of treatment-seeking illicit drug abusers in Finland, 1997-2008: the Huuti study. J Addict Dis. 2012; 31(4):350-62. DOI: 10.1080/10550887.2012.735563. View

11.

Walters J, Ward G, Barton J, Arackal R, Boston R, Best J . The effect of norepinephrine on insulin secretion and glucose effectiveness in non-insulin-dependent diabetes. Metabolism. 1998; 46(12):1448-53. DOI: 10.1016/s0026-0495(97)90146-3. View

12.

Warner E, Greene G, Buchsbaum M, Cooper D, Robinson B . Diabetic ketoacidosis associated with cocaine use. Arch Intern Med. 1998; 158(16):1799-802. DOI: 10.1001/archinte.158.16.1799. View

13.

Isidro M, Jorge S . Recreational drug abuse in patients hospitalized for diabetic ketosis or diabetic ketoacidosis. Acta Diabetol. 2010; 50(2):183-7. DOI: 10.1007/s00592-010-0243-z. View

14.

Gerich J, Lorenzi M, Tsalikian E, KARAM J . Studies on the mechanism of epinephrine-induced hyperglycemia in man. Evidence for participation of pancreatic glucagon secretion. Diabetes. 1976; 25(1):65-71. DOI: 10.2337/diab.25.1.65. View

15.

Lee P, Greenfield J, Campbell L . Managing young people with Type 1 diabetes in a 'rave' new world: metabolic complications of substance abuse in Type 1 diabetes. Diabet Med. 2009; 26(4):328-33. DOI: 10.1111/j.1464-5491.2009.02678.x. View

16.

Jacobsen L, Haller M, Parish A, Gurka M, Levine S, Wasserfall C . High Illicit Drug Abuse and Suicide in Organ Donors With Type 1 Diabetes. Diabetes Care. 2017; 40(9):e122-e123. DOI: 10.2337/dc17-0996. View

17.

Harjutsalo V, Forsblom C, Groop P . Time trends in mortality in patients with type 1 diabetes: nationwide population based cohort study. BMJ. 2011; 343:d5364. PMC: 3169676. DOI: 10.1136/bmj.d5364. View

18.

Kovacs M, Charron-Prochownik D, Obrosky D . A longitudinal study of biomedical and psychosocial predictors of multiple hospitalizations among young people with insulin-dependent diabetes mellitus. Diabet Med. 1995; 12(2):142-8. DOI: 10.1111/j.1464-5491.1995.tb00445.x. View

19.

Kaye S, McKetin R, Duflou J, Darke S . Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction. 2007; 102(8):1204-11. DOI: 10.1111/j.1360-0443.2007.01874.x. View

20.

Gale E, Gillespie K . Diabetes and gender. Diabetologia. 2001; 44(1):3-15. DOI: 10.1007/s001250051573. View